A database study built a risk model containing several medicines and illness variables. Midazolam’s inclusion was predictive evidence, not proof of drug-induced brain dysfunction.
The prediction exercise
The investigators used records from 2,028 sepsis patients and developed a nomogram after feature selection. The model included age, illness assessment, midazolam, and several other medicines.
Its reported discrimination was about 0.74, with internal assessments of calibration and decision utility.
What remains unestablished
Routine records can contain coding and measurement limitations, and the study lacked external validation. Medication administration may reflect clinical severity or an evolving neurological problem. Feature timing and the outcome definition therefore matter.
A model cannot show that withholding one included drug would prevent encephalopathy. Nor can a moderate prediction score establish the cause of an individual episode. The paper supports further risk-model testing, while the clinical opinion still requires infection context, baseline cognition, sedative timing, neurological assessment, and alternative explanations.
Source paper
Original analysis of the supplied journal article, identified as PMC8636425.
Leave a Reply